A
Arti
About Arti
Data last updated:
Arti has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Lewis Bioserch Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Lewis Bioserch Pharma Private Limited at ₹4.94 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Lewis Bioserch Pharma Private Limited U24100CH2012PTC033656 | Director | 21 Jan 2023 | 2012 | ₹4.94 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Arti
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arti
Arti has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Lewis Bioserch Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Lewis Bioserch Pharma Private Limited at ₹4.94 Cr (FY 2024).
Arti is associated with 1 company as Director, including Lewis Bioserch Pharma Private Limited (₹4.94 Cr).
Arti has expertise in General Business.
Arti has 3 years in corporate governance.
By reported revenue, the largest current company of Arti is Lewis Bioserch Pharma Private Limited, with revenue of ₹4.94 Cr (FY 2024).
Arti currently holds positions at 1 company: Lewis Bioserch Pharma Private Limited (₹4.94 Cr).